"Signed Chinese distribution agreements with Yung Shin Pharm to register and distribute ASTRIX low dose capsules and with Novotek Pharmaceuticals to register and distribute KAPANOL sustained-release capsule"
So into Chinese markets now and that should be good news. However, market initial hype faded quickly.
Ann: 2019 Annual Report, page-2
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.37 |
Change
-0.010(0.23%) |
Mkt cap ! $371.7M | |||
| Open | High | Low | Value | Volume |
| $4.39 | $4.44 | $4.35 | $309.7K | 70.59K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 544 | $4.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.39 | 139 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |